期刊文献+

CD105和MMP-2在子宫腺肌病组织中的表达及意义

Expression and Significance of MMP-2 and CD105 in Adenomyosis
下载PDF
导出
摘要 目的探讨以CD105标记的微血管密度(MVD)与MMP-2在子宫腺肌病中的表达与发病机制的关系。方法收集我院2005-01~2006-01间治疗的30例子宫腺肌病病例,采用免疫组织化学染色检测子宫腺肌病在位组及异位组子宫内膜CD105、MMP-2的表达,并运用图像分析仪检测CD105标记的MVD。结果以CD105标记的MVD异位组为24.19±5.30,在位组为17.89±4.53,异位组子宫内膜中表达显著高于在位组子宫内膜(P〈0.05),在位组子宫内膜分泌期MVD18.09±3.60、增生期17.69±5.57,无显著差异(P〉0.05);MMP-2在子宫腺肌病异位组内膜的阳性表达率76.67%(23/30),在位组阳性表达率为46.67%(14/30),异位组内膜的表达水平显著高于在位组子宫内膜(P〈0.05),在位组子宫内膜分泌期MMP-2的阳性表达率显著高于增生期(P〈0.05)。经过spearman相关性分析,MMP-2阳性率的表达与MVD呈显著正相关关系(r=0.489,P〈0.01)。结论CD105和MMP-2的过度表达与子宫腺肌病新生血管的生成有关,在子宫腺肌病发病过程中发挥重要作用,是子宫腺肌病具有侵袭性生长的原因之一。 Objective To investigate the expression of MMP-2 and CD105 in the eutopie and ectopie endometrium of adenomyosis and their relation with pathogenesis of adenomyosis. Methods Enometrial specimens were obtained from 30 cases with adenomyosis. MMP - 2 were detected by immtmohistochemical taining, microvessels were highlighted by immtmohistochemical staining by detected CD105. the average microvessels counted per field(400 × ) were obtained by use of a computerized image analysis system. Results The expression of MVD in the ectopic endometrium and in the dutopic endometrium of adenomyosis tissues were 24.19 ± 5.30,17.89 ± 4.53, the expression of MVD in two group above had significant difference ( P 〈 0.05), The expression of MVD in the eutopic endometrium of secretory phase was not significantly higher than that of proliferative phase ( P 〉 0.05) ;The positive expression of MMP- 2 in the eetopic endometrium and in the entopic endometrium were 76.67%(23/30) and 46.67%(14/30).The expression of MMP-2 in the eetopic endometrium of adenomyosis was significantly higher than that in the eutopic endometrium of adenomyosis ( P 〈 0.05) .The expression of MMP- 2 in the eutopic of adenomyosis of secretory phase was signiflcandy higher than that of proliferative phase( P 〈 0.05) ;MVD was significandy correlated with the expression of MMP-2( r =0.489, P 〈 0.01).Conclusion The overexpression of MMP-2 and MMP-2 significantly have close relationship with angiogenesis of adenomyosis which play an important role in adenomyosis, and participate in the process of invasion.
出处 《黑龙江医学》 2007年第5期321-323,共3页 Heilongjiang Medical Journal
关键词 子宫腺肌病 血管生成 CD105 MMP-2 MVD Adenomyosis Angiogenesis CD105 MMP-2 MVD
  • 相关文献

参考文献12

  • 1Matsuzaki S,Canis M,Murakami T,et al.Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis[J].Fertil Steril,2001,76:712~716.
  • 2Sillem M,Hahn U,Coddington C C,et al.Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey(Macaca fascicularis)model of endometriosis[J].Fertil Steril,1998,66(3):468~473.
  • 3Weidner N,Semple J P,Welch W R,et al.Tumor angiogenesis and metastasis:correlation in invasive breast carcinoma[J].N Engl J Med,1991,324(1):1~8.
  • 4Saitoh Y,Yaginuma Y,Ishikawa M.Analysis of bc1-2,bax and surviving genes in uterine cancer[J].Int J Oncol,1995,5(1):137~141.
  • 5Kumar P,Wang J M,Bernabeu C.CD105 and angiogenesis[J].Pathol,1996,178:363~366.
  • 6Brewer C A,Setterdahl J J,Li M J,et al.Endoglin expression as a measure of microvessel density in cervical cancer[J].Obstet Gynecol,2000,96:224~228.
  • 7Tanka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody[J].Glin Cancer Res,2001,7(11):3 410~3 415.
  • 8Tabata M,Kondo M,Haruta Y,et al.Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using(125)Ⅰ-labeled anti-endoglin monoclonal antibodies[J].Int J Cancer,1999,82(5):737~742.
  • 9Mclare J,Prentice A,Charnock Jones D S,et al.Vascular endothelial growth factor concentrations are elevated in peritoneal fluid of women with endometriosis[J].Hum Reprod,1996 Jan,11(1):220~223.
  • 10陈莉,黄曙光,许培箴,刘嘉茵.CD105在子宫腺肌病中的表达及其临床意义[J].中国血液流变学杂志,2006,16(2):258-260. 被引量:2

二级参考文献12

  • 1Fonsaui E,Sigalotti I,Arslan P,et al.Emerging role ofendoglin (CD105) as a marker ofangiogenesis with clinical potential in human malignancies[J].Curr Cancer Drug Targets,2003,3(6):427~432.
  • 2Cheifetz S,Bellon T,Cales C,et al.Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cell[J].J Biol Chem,1992,267(27):19027~19030.
  • 3Hirakawa S,Hong YK,Harvey N,et al.ldentification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cell[J].Am J Pathol,2003,162(2):575~586.
  • 4Vande KerkhofPC,Rulo HF,Van JP,et al.Expression of endoglin in thetransition between psoriatic uninvolved and involved skin[J].Acta Derm Venereol,1998,78(1):19~21.
  • 5Li C,Guo B,Wilson PB,et al.Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer[J].Int J Cancer,2000,89(2):122~126.
  • 6Mclare J,Prentice A,Charnock Jones DS et al.Vascular endothelial growth factor concentrations are elevatered 8in peritoneal fluid of women with endometriosis[J].Hum Reprod,1996,11 (1):220~223.
  • 7Zhou YE,Matsuda M,Sakamoto S,et al.Changes in uterine microvessels as a possible pathogenic factor in the development of adenomyosis induced by pituitary grafting in mice[J].Acta Histocherm Cytochem,1999,32:387~391.
  • 8Song JY,Markham R,Russell P,et al.The effect of high dose medium and long term progestogen exposure on endometrial vessel[J].Hum Reprod,1995,10:797~800.
  • 9Charnock-Jones DS,Sharkey AM,Rajput-Williams J.Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines[J].Biol Reprod,1993,48:1120~1128.
  • 10吕立群,朱桂金,刘义,艾继辉.子宫内膜异位症在位与异位子宫内膜血管发生研究[J].同济医科大学学报,2001,30(3):252-254. 被引量:4

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部